Cargando…
Simulation model of disease incidence driven by diagnostic activity
It is imperative to understand the effects of early detection and treatment of chronic diseases, such as prostate cancer, regarding incidence, overtreatment and mortality. Previous simulation models have emulated clinical trials, and relied on extensive assumptions on the natural history of the dise...
Autores principales: | Westerberg, Marcus, Larsson, Rolf, Holmberg, Lars, Stattin, Pär, Garmo, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894333/ https://www.ncbi.nlm.nih.gov/pubmed/33241594 http://dx.doi.org/10.1002/sim.8833 |
Ejemplares similares
-
Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
por: Bergengren, Oskar, et al.
Publicado: (2021) -
Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
por: Thomsen, Frederik B., et al.
Publicado: (2020) -
Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy
por: Orrason, Andri Wilberg, et al.
Publicado: (2022) -
Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
por: Corsini, Christian, et al.
Publicado: (2023) -
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
por: Robinson, David, et al.
Publicado: (2015)